PharmaSynth AS
- Registry code
- 11044101
- VAT number
- EE100940196
- Address
- Tartu maakond, Tartu linn, Tartu linn, Teaduspargi tn 7, 50411
- Registered
- 29.06.2004 · 22 yrs
- Activity
- Manufacture of basic pharmaceutical products 21101
- Capital
- 57 180 €
- p•••@p•••.eeLog in to see
- Phone
- +372 •• ••••Log in to see
- Website
- https://www.pharmasynth.ee
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
2 persons
| Board 1 | ||
|---|---|---|
| Pirkko Irene Penttilä-Hiltunen3 companiesno tax debt | Personal ID ↗ | 17.10.2022 |
| Muud isikud 1 | ||
| Nasdaq CSD SE5342 companies434 with tax debt91 pankrotisAktsiaraamatu pidaja | Personal ID ↗ | 28.09.2017 |
| Beneficial owners 1 | ||
| Jukka Veli Hiltunenotsene osalus | 29.07.2021 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 198 786 € | ▼ 3% | 42 809 € | 40 112 € | 9 |
| 2026 Q1 | 131 408 € | ▼ 43% | 46 184 € | 42 273 € | 10 |
| 2025 Q4 | 226 815 € | ▲ 57% | 48 589 € | 45 240 € | 11 |
| 2025 Q3 | 76 881 € | ▼ 59% | 46 593 € | 43 134 € | 11 |
| 2025 Q2 | 205 836 € | ▲ 96% | 39 265 € | 36 887 € | 10 |
| 2025 Q1 | 231 372 € | ▲ 66% | 47 436 € | 44 449 € | 9 |
| 2024 Q4 | 144 888 € | ▲ 41% | 42 231 € | 39 879 € | 9 |
| 2024 Q3 | 188 774 € | ▼ 0% | 35 984 € | 34 016 € | 9 |
| 2024 Q2 | 105 109 € | ▼ 28% | 35 258 € | 33 098 € | 8 |
| 2024 Q1 | 139 707 € | ▼ 28% | 32 989 € | 31 248 € | 8 |
| 2023 Q4 | 102 827 € | ▼ 26% | 32 096 € | 30 656 € | 8 |
| 2023 Q3 | 189 320 € | ▲ 74% | 31 857 € | 30 191 € | 8 |
Näita kogu ajalugu (18 kvartalit)
| 2023 Q2 | 144 998 € | ▲ 28% | 36 061 € | 34 125 € | 8 |
| 2023 Q1 | 194 811 € | ▲ 57% | 31 743 € | 30 068 € | 8 |
| 2022 Q4 | 139 706 € | 25 556 € | 24 295 € | 8 | |
| 2022 Q3 | 108 932 € | 19 929 € | 19 036 € | 8 | |
| 2022 Q2 | 113 668 € | 15 588 € | 16 704 € | 8 | |
| 2022 Q1 | 124 229 € | 20 015 € | 19 012 € | 7 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
5 yr
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Sales revenue | 896 k € | ▲ 53% | 587 k € | ▼ 8% | 635 k € | ▲ 34% | 476 k € | ▼ 7% | 511 k € |
| Profit | 236 k € | ▲ 55% | 152 k € | ▲ 5% | 145 k € | ▲ 20% | 121 k € | ▼ 51% | 248 k € |
| Profit margin | 26,3% | 25,9% | 22,9% | 25,5% | 48,5% | ||||
| Jaotamata kasum | 985 k € | ▲ 18% | 833 k € | ▲ 21% | 687 k € | ▲ 22% | 562 k € | ▲ 79% | 315 k € |
| Cash | 679 k € | ▼ 9% | 743 k € | ▲ 13% | 658 k € | ▲ 22% | 541 k € | ▲ 7% | 504 k € |
| Current assets | 1,2 m € | ▲ 22% | 969 k € | ▲ 24% | 783 k € | ▲ 23% | 636 k € | ▲ 8% | 589 k € |
| Põhivara | 185 k € | ▲ 20% | 155 k € | ▼ 2% | 157 k € | ▼ 20% | 198 k € | ▲ 119% | 90 310 € |
| Assets | 1,4 m € | ▲ 22% | 1,1 m € | ▲ 19% | 941 k € | ▲ 13% | 833 k € | ▲ 23% | 679 k € |
| Current liabilities | 84 409 € | ▲ 12% | 75 325 € | ▲ 69% | 44 535 € | ▼ 46% | 82 591 € | ▲ 66% | 49 756 € |
| Total liabilities | 84 409 € | ▲ 12% | 75 325 € | ▲ 69% | 44 535 € | ▼ 46% | 82 591 € | ▲ 66% | 49 756 € |
| Equity | 1,3 m € | ▲ 23% | 1,0 m € | ▲ 17% | 896 k € | ▲ 19% | 751 k € | ▲ 19% | 629 k € |
| Tööjõukulud | -423 k € | ▼ 13% | -373 k € | ▼ 25% | -298 k € | ▼ 34% | -223 k € | ▼ 26% | -177 k € |
| Employees | 9 | ▲ 12% | 8 | ▲ 14% | 7 | 0% | 7 | 0% | 7 |
| Filed | 29.06.2026 | 30.06.2025 | 26.06.2024 | 21.06.2023 | 02.03.2023 | ||||
| Report | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ |
▲ kasv, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Manufacture of basic pharmaceutical products main activity | 21101 | 896 270 € | 100% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
4 650 € makseid · 2 toetust
Tehingud riigiasutustega
Suurimad maksjad
| Riigi Infosüsteemide Amet | 4 650 € |
Kõik maksed kuude kaupa
| Kuu | Maksja | Liik | Field | Amount |
|---|---|---|---|---|
| 02.2025 | Riigi Infosüsteemide Amet | Muud toetused | Teadus- ja arendustegevus sides | 4 650 € |
Riigi Tugiteenuste Keskus, Saldo makseandmikud
Toetuse saanud projektid
| Projekt | Meede | Periood | Toetus | Välja makstud |
|---|---|---|---|---|
| Ekspordivõimaluste arendus: Ameerika, Aasia ja Austraalia turud Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Välismessitoetus | 30.08.2010 – 30.09.2010 | 3 899 € | |
| Fluorodesoksüglükoosi kui PET markeri prekursor (FDG-PET precursor) Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Teadus- ja arendustegevuse, innovatsiooni edendamine | 25.01.2008 – 25.05.2008 | 15 297 € |
Riigi Tugiteenuste Keskus, toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
60
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Manufacture of basic pharmaceutical products
8
| # | Company | Revenue |
|---|---|---|
| 1 | Acino Estonia OÜ | 32,7 m € |
| 2 | osaühing TBD Pharmatech | 5,1 m € |
| 3 | Nordaid OÜ | 981 k € |
| 4 | PharmaSynth AS | 896 k € |
| 5 | osaühing REVELIKO | 51 846 € |
| 6 | Chemipower OÜ | 14 000 € |
| 7 | Plantor OÜ | 2 614 € |
| 8 | Bestafter OÜ | 100 € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Domains
1 records
Domains
| Domain | Source |
|---|---|
| pharmasynth.ee | Business Register |
History and notices
17
| Date | Liik | Sisu |
|---|---|---|
| 19.07.2023 | Kanne | Muutmiskanne |
| 02.03.2023 | Kanne | Muutmiskanne |
| 17.10.2022 | Kanne | Muutmiskanne |
| 29.07.2022 | Kandemäärus ex officio | Muutmiskanne |
| 15.06.2022 | Puuduste kõrvaldamise määrus | Muutmiskanne |
| 22.02.2019 | Kanne | Muutmiskanne ÄS § 525 lg 2 alusel |
| 13.09.2018 | Kustutamishoiatuse avaldamine Ametlikes Teadaannetes | |
| 09.03.2018 | Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata | |
| 18.01.2018 | Kanne | Muutmiskanne |
| 23.12.2017 | Kanne | Muutmiskanne |
| 03.12.2017 | Kanne | Muutmiskanne |
| 28.09.2017 | Kanne | Muutmiskanne |
| 10.05.2017 | Kanne | Muutmiskanne |
| 03.12.2008 | Tegevusalade kustutamine registrikaardilt | Muutmiskanne |
| 30.11.2006 | Trahvihoiatusmäärus: majandusaasta aruande puuduste kohta | |
| 10.10.2006 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | Toimiku dokumentide kontroll |
| 28.06.2004 | Jaatav kandeotsus | Esmakanne |